You are using an outdated browser. Please upgrade your browser to improve your experience.

You are using an outdated browser.

To ensure optimal security, this website will soon be unavailable on this browser. Please upgrade your browser to allow continued use of ACP websites.

SGLT2 Inhibitors: The Good, the Bad, and the Ugly

Annals on Call

In this episode of Annals On Call, Dr. Centor discusses the risks and benefits of using SGLT2 inhibitors to treat patients with type 2 diabetes with Dr. Katherine Tuttle, an endocrinologist and nephrologist at Washington State University.

First, listen to the podcast. After listening, ACP members can take the CME/MOC quiz for free.


Up to 1 AMA PRA Category 1 Credits ™ and MOC Points
Expires August 7, 2022   expired


Free to Members


Podcasts and Audio Content


Annals on Call

Each Annals On Call podcast features Dr. Bob Centor discussing and debating a clinically influential article published in Annals of Internal Medicine with a guest expert.